• Saltar a la navegación principal
  • Saltar al contenido principal
  • Saltar al pie de página
ILAPHAR | Revista de la OFIL

ILAPHAR | Revista de la OFIL

Revista de la Organización de Farmacéuticos | Ibero-latinoamericanos | Ibero Latin American Journal of Health System Pharmacy

  • Números de la revista
  • Sobre la Revista
  • Eventos y Publicaciones

Oncologic drugs influence on driving ability

Fecha de recepción: 03/09/2018  –  Fecha de aceptación: 15/10/2018

Medina Guerrero A, García Muñoz S, Bellver Albertos M, García Martínez T, Lorente Fernández L, Soler Company E

Servicio de Farmacia. Hospital Arnau de Vilanova-Lliria. Valencia (España)

____

Correspondencia:

Álvaro Medina Guerrero w Hospital Arnau de Vilanova w C/San Clemente 12 w 46015 Valencia (España)

medina_alv@gva.es

____

Summary

Objectives: To evaluate knowledge that patients have on cancer treatment on the possible involvement in driving produced by medications, as well as the level of appreciation of the risk. To identify the appearance of adverse drugs reactions associated with these drugs and their relationship with the perceived changes in the way of driving. From the results obtained, implement improvements in the information circuits and introduce as a new variable in decision-making the influence on driving.

Material and methods: Prospective, descriptive and transversal study developed in the outpatient pharmaceutical unit and day hospital of our health department, from February to April 2018. The population under study was the patients in treatment with oncologic drugs that influence driving.

Results: We included 107 patients who had a driving license and received treatment with antineoplastic agents. 57.9% were unaware of the existence of the driving pictogram and 48.6% did not know its meaning. 38.3% of patients reported the appearance of adverse reactions that could interfere with driving since they had begun treatment with the drugs under study, and 11.2% had perceived differences in their driving.

Conclusions: The appearance of adverse reactions associated with the studied drugs is directly related to the perception of changes in the way of driving.

The current driving pictogram is not informative enough for patients. Identify these needs, is the starting point to develop new information channels that ensure their correct understanding.

Key Words: Antineoplastic agents, automobile driving, patient-related outcomes, adverse drug reactions.

____

Download PDF: Influencia de los medicamentos oncológicos en la capacidad de conducción

Footer

Footer 1

ISSN Edición impresa: 1131-9429
ISSN Edición electrónica: 1699-714X

Web diseñada y desarrollada por Company Valor